[1]汪秀玲,侯先存,徐凯.核医学显像在乳腺癌诊疗中的作用[J].国际放射医学核医学杂志,2006,30(4):222-224.
 WANG Xiu-ling,HOU Xian-cun,XU Kai.The effection of nuclear medicine in the diagnosis and treat of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):222-224.
点击复制

核医学显像在乳腺癌诊疗中的作用(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
30
期数:
2006年第4期
页码:
222-224
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The effection of nuclear medicine in the diagnosis and treat of breast cancer
作者:
汪秀玲 侯先存 徐凯
221002 徐州, 徐州医学院附属医院影像科
Author(s):
WANG Xiu-ling HOU Xian-cun XU Kai
Department of Imaging, The Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China
关键词:
乳腺肿瘤放射性核素显像
Keywords:
Breast neoplasmsRadionuclide imaging
分类号:
R817.4
摘要:
乳腺癌发病率逐年增高,诊疗技术也不断发展,核医学检查在乳腺癌诊疗中起到重要作用,如用于乳腺癌诊断的乳腺闪烁显像,放射性核素对前哨淋巴结的检出,检查骨转移的骨闪烁显像及PET在乳腺癌原发灶诊断的应用等。
Abstract:
The incidence of breast cancer has been increasing recently. Nuclear medicine plays an important role in the diagnosis and treat of breast cancer:breast scintigraphy in the diagnosis of breast cancer, the detection of sentinel lymph node using radioisotope, skeleton scintigraphy in the diagnosis of osseous metastasis, the application of PET in breast cancer, for instance.

参考文献/References:

1 Koizumi M.Nuclear medicine in breast cancer.Jpn J Diagn Imaging,2005,25(10):1257-1263.
2 Bagni B,Franceschetto A,Casolo A,et al.Seintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer.Eur J Nuel Med Mol Imaging,2003,30(11):1383-1388.
3 Aursvold JN,Alazraki NP.Updata on detection of sentinel lymph nodes in patients with breast cancer.Semin Nucl Med,2005,35(1):116-128.
4 Koizumi M,Nomura E,Yamada Y,et al.Radioguided sentinel node detection in breast cancer patients:comparion of 99mTc phytate and 99mTc rheninum colloid efficary.Nucl Med Commun,2004,25(9):1031-1034.
5 Veronesi U,Paganellic G,Viale G,et al.A randomized comparion of sentinel-node biopsy with routine axillary dissection in breast cancer.N Engl J Med,2003,349(6):546-553.
6 Kimiihi Uno,Jin Wu,Weijeyko,et al.Diagnostic imaging using FDG-PET in breast cancer.Jpn J Diagn Imaging,2005,25(9):1120-1128.
7 Avri N,Rose CA,Schelling M,et al.Breast imaging with position emission tomography and[fluoro-18]-fluorodeoxyglucose:use and limitation.J Clin Oncol,2000,18(12):3495-3502.
8 Eubank WB,Mankoff DA.Erovling role of position emission tomography in breast cancer imaging.Semin Nucl Med,2005,35(1):84-99.
9 Wahl RL,Siegel BA,Coleman RE,et al.Prospective multicenter study of axillary nodel staging with FDG position emission tomography in breast cancer.J Clin Oncol,2004,22(3):277-285.
10 Suarez M,Petez-castejon MJ,Jimenez A,et al.Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.Q J Nucl Med,2002,46(1):113-121.
11 Eubank WB,Mankoff DA,Bhattacharya M,et al.Impact of[F-18]-fluorodeoxyglucose PET on defining the extent of disease and mamagement of patients with recurrent or metastatic breast cancer.AJR,2004,183(2):479-486.

相似文献/References:

[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
 Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[2]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
 Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
 Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]孙芳芳,张欣.uPAR放射性核素靶向显像研究进展[J].国际放射医学核医学杂志,2016,40(3):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
 Sun Fangfang,Zhang Xin.Research progress of uPAR-targeted nuclear imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
[5]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
 chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
[6]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
 An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[7]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
 Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[8]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
 Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[9]黄建敏,解朋,刘晓梅,等.以整合素αvβ3为靶点的肿瘤分子显像及靶向治疗[J].国际放射医学核医学杂志,2015,39(3):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
 Huang Jianmin,Xie Peng,Liu Xiaomei,et al.Integrins αvβ3 in molecular imaging and targeted therapy of neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
[10]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
 Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
[11]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
 Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[12]关晏星.乳腺癌核素分子显像的临床研究进展[J].国际放射医学核医学杂志,2006,30(4):225.
 GUAN Yan-xing.Clinic applicatim and propgress of the nuclide molecular imaging in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):225.
[13]郭睿,晋建华.99mTc-depreotide生长抑素受体显像的临床应用研究[J].国际放射医学核医学杂志,2007,31(3):154.
 GUO Rui,JIN Jian-hua.The clinical application and study of 99mTc-depreotide somatostatin receptor imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):154.

备注/Memo

备注/Memo:
收稿日期:2005-11-23。
通讯作者:汪秀玲,E-mail:xuzhouwangxl@hotmail.com
更新日期/Last Update: 1900-01-01